Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $1.44 in the prior trading day, Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) closed at $1.42, down -1.39%. In other words, the price has decreased by -$1.39 from its previous closing price. On the day, 64588.0 shares were traded. SONN stock price reached its highest trading level at $1.5 during the session, while it also had its lowest trading level at $1.41.
Ratios:
Our goal is to gain a better understanding of SONN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 0.66.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SONN now has a Market Capitalization of 4270550 and an Enterprise Value of -2229971. For the stock, the TTM Price-to-Sale (P/S) ratio is 218.00. Its current Enterprise Value per Revenue stands at -39.906 whereas that against EBITDA is 0.182.
Stock Price History:
Over the past 52 weeks, SONN has reached a high of $18.72, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is -57.41%, while the 200-Day Moving Average is calculated to be -83.26%.
Shares Statistics:
The stock has traded on average 1.31M shares per day over the past 3-months and 363700 shares per day over the last 10 days, according to various share statistics. A total of 3.01M shares are outstanding, with a floating share count of 2.87M. Insiders hold about 4.41% of the company’s shares, while institutions hold 0.01% stake in the company. Shares short for SONN as of 1732838400 were 40115 with a Short Ratio of 0.03, compared to 1730332800 on 66231. Therefore, it implies a Short% of Shares Outstanding of 40115 and a Short% of Float of 4.8499998.
